Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study.

Pediatr Rheumatol Online J · 2025 · PMC11841336 · PMID 39972375

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Effect of abatacept on growth An increasing trend was observed in the mean (SD) of height and weight SDS over time for the overall patients.

also in 63,971 other papers

a decreasing trendno p-value reported

Time course of MMP-3 levels A decreasing trend in the MMP-3 levels from baseline to 52 weeks after abatacept administration over time was observed for the overall patients and responders, although no statistical test was performed (Figures 6 a and 6c).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.